Silverarc Capital Management’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-26,219
| Closed | -$227K | – | 60 |
|
|
2024
Q3 | $227K | Sell |
26,219
-2
| -0% | -$17 | 0.05% | 66 |
|
|
2024
Q2 | $229K | Hold |
26,221
| – | – | 0.05% | 64 |
|
|
2024
Q1 | $642K | Sell |
26,221
-519
| -2% | -$12.7K | 0.18% | 65 |
|
|
2023
Q4 | $444K | Buy |
26,740
+1,465
| +6% | +$24.3K | 0.13% | 61 |
|
|
2023
Q3 | $472K | Hold |
25,275
| – | – | 0.14% | 59 |
|
|
2023
Q2 | $614K | Hold |
25,275
| – | – | 0.19% | 63 |
|
|
2023
Q1 | $552K | Buy |
+25,275
| New | +$552K | 0.23% | 60 |
|
|
2022
Q3 | – | Sell |
-2,336
| Closed | -$71K | – | 70 |
|
|
2022
Q2 | $71K | Buy |
2,336
+1,910
| +448% | +$58.1K | 0.02% | 57 |
|
|
2022
Q1 | $23 | Buy |
+426
| New | +$23 | 0.01% | 64 |
|